Edvard O.S. Grødem , Esten Leonardsen , Bradley J. MacIntosh , Atle Bjørnerud , Till Schellhorn , Øystein Sørensen , Inge Amlien , Anders M. Fjell , Alzheimer’s Disease Neuroimaging Initiative
{"title":"利用简单、极小的卷积神经网络对阿尔茨海默病进行分类的简约方法。","authors":"Edvard O.S. Grødem , Esten Leonardsen , Bradley J. MacIntosh , Atle Bjørnerud , Till Schellhorn , Øystein Sørensen , Inge Amlien , Anders M. Fjell , Alzheimer’s Disease Neuroimaging Initiative","doi":"10.1016/j.jneumeth.2024.110253","DOIUrl":null,"url":null,"abstract":"<div><h3>Background:</h3><p>There is a broad interest in deploying deep learning-based classification algorithms to identify individuals with Alzheimer’s disease (AD) from healthy controls (HC) based on neuroimaging data, such as T1-weighted Magnetic Resonance Imaging (MRI). The goal of the current study is to investigate whether modern, flexible architectures such as EfficientNet provide any performance boost over more standard architectures.</p></div><div><h3>Methods:</h3><p>MRI data was sourced from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and processed with a minimal preprocessing pipeline. Among the various architectures tested, the minimal 3D convolutional neural network SFCN stood out, composed solely of 3x3x3 convolution, batch normalization, ReLU, and max-pooling. We also examined the influence of scale on performance, testing SFCN versions with trainable parameters ranging from 720 up to 2.9 million.</p></div><div><h3>Results:</h3><p>SFCN achieves a test ROC AUC of 96.0% while EfficientNet got an ROC AUC of 94.9 %. SFCN retained high performance down to 720 trainable parameters, achieving an ROC AUC of 91.4%.</p></div><div><h3>Comparison with existing methods:</h3><p>The SFCN is compared to DenseNet and EfficientNet as well as the results of other publications in the field.</p></div><div><h3>Conclusions:</h3><p>The results indicate that using the minimal 3D convolutional neural network SFCN with a minimal preprocessing pipeline can achieve competitive performance in AD classification, challenging the necessity of employing more complex architectures with a larger number of parameters. This finding supports the efficiency of simpler deep learning models for neuroimaging-based AD diagnosis, potentially aiding in better understanding and diagnosing Alzheimer’s disease.</p></div>","PeriodicalId":16415,"journal":{"name":"Journal of Neuroscience Methods","volume":"411 ","pages":"Article 110253"},"PeriodicalIF":2.7000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0165027024001985/pdfft?md5=a67a2cd29e6051ebf7457b24f1b2b10f&pid=1-s2.0-S0165027024001985-main.pdf","citationCount":"0","resultStr":"{\"title\":\"A minimalistic approach to classifying Alzheimer’s disease using simple and extremely small convolutional neural networks\",\"authors\":\"Edvard O.S. Grødem , Esten Leonardsen , Bradley J. MacIntosh , Atle Bjørnerud , Till Schellhorn , Øystein Sørensen , Inge Amlien , Anders M. Fjell , Alzheimer’s Disease Neuroimaging Initiative\",\"doi\":\"10.1016/j.jneumeth.2024.110253\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background:</h3><p>There is a broad interest in deploying deep learning-based classification algorithms to identify individuals with Alzheimer’s disease (AD) from healthy controls (HC) based on neuroimaging data, such as T1-weighted Magnetic Resonance Imaging (MRI). The goal of the current study is to investigate whether modern, flexible architectures such as EfficientNet provide any performance boost over more standard architectures.</p></div><div><h3>Methods:</h3><p>MRI data was sourced from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and processed with a minimal preprocessing pipeline. Among the various architectures tested, the minimal 3D convolutional neural network SFCN stood out, composed solely of 3x3x3 convolution, batch normalization, ReLU, and max-pooling. We also examined the influence of scale on performance, testing SFCN versions with trainable parameters ranging from 720 up to 2.9 million.</p></div><div><h3>Results:</h3><p>SFCN achieves a test ROC AUC of 96.0% while EfficientNet got an ROC AUC of 94.9 %. SFCN retained high performance down to 720 trainable parameters, achieving an ROC AUC of 91.4%.</p></div><div><h3>Comparison with existing methods:</h3><p>The SFCN is compared to DenseNet and EfficientNet as well as the results of other publications in the field.</p></div><div><h3>Conclusions:</h3><p>The results indicate that using the minimal 3D convolutional neural network SFCN with a minimal preprocessing pipeline can achieve competitive performance in AD classification, challenging the necessity of employing more complex architectures with a larger number of parameters. This finding supports the efficiency of simpler deep learning models for neuroimaging-based AD diagnosis, potentially aiding in better understanding and diagnosing Alzheimer’s disease.</p></div>\",\"PeriodicalId\":16415,\"journal\":{\"name\":\"Journal of Neuroscience Methods\",\"volume\":\"411 \",\"pages\":\"Article 110253\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-08-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0165027024001985/pdfft?md5=a67a2cd29e6051ebf7457b24f1b2b10f&pid=1-s2.0-S0165027024001985-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Neuroscience Methods\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0165027024001985\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuroscience Methods","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165027024001985","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
A minimalistic approach to classifying Alzheimer’s disease using simple and extremely small convolutional neural networks
Background:
There is a broad interest in deploying deep learning-based classification algorithms to identify individuals with Alzheimer’s disease (AD) from healthy controls (HC) based on neuroimaging data, such as T1-weighted Magnetic Resonance Imaging (MRI). The goal of the current study is to investigate whether modern, flexible architectures such as EfficientNet provide any performance boost over more standard architectures.
Methods:
MRI data was sourced from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and processed with a minimal preprocessing pipeline. Among the various architectures tested, the minimal 3D convolutional neural network SFCN stood out, composed solely of 3x3x3 convolution, batch normalization, ReLU, and max-pooling. We also examined the influence of scale on performance, testing SFCN versions with trainable parameters ranging from 720 up to 2.9 million.
Results:
SFCN achieves a test ROC AUC of 96.0% while EfficientNet got an ROC AUC of 94.9 %. SFCN retained high performance down to 720 trainable parameters, achieving an ROC AUC of 91.4%.
Comparison with existing methods:
The SFCN is compared to DenseNet and EfficientNet as well as the results of other publications in the field.
Conclusions:
The results indicate that using the minimal 3D convolutional neural network SFCN with a minimal preprocessing pipeline can achieve competitive performance in AD classification, challenging the necessity of employing more complex architectures with a larger number of parameters. This finding supports the efficiency of simpler deep learning models for neuroimaging-based AD diagnosis, potentially aiding in better understanding and diagnosing Alzheimer’s disease.
期刊介绍:
The Journal of Neuroscience Methods publishes papers that describe new methods that are specifically for neuroscience research conducted in invertebrates, vertebrates or in man. Major methodological improvements or important refinements of established neuroscience methods are also considered for publication. The Journal''s Scope includes all aspects of contemporary neuroscience research, including anatomical, behavioural, biochemical, cellular, computational, molecular, invasive and non-invasive imaging, optogenetic, and physiological research investigations.